16 results
8-K
EX-2.3
ADIL
Adial Pharmaceuticals, Inc.
21 Sep 23
Entry into a Material Definitive Agreement
4:10pm
and customer and supplier lists and information), (g) other intellectual property rights, and (h) copies and tangible embodiments thereof (in whatever
POS AM
ADIL
Adial Pharmaceuticals, Inc.
24 Jun 22
Prospectus update (post-effective amendment)
5:11pm
impact our key clinical trial vendors and supplier of our active pharmaceutical ingredient. The full extent to which the COVID-19 pandemic impacts
POS AM
ADIL
Adial Pharmaceuticals, Inc.
24 Jun 22
Prospectus update (post-effective amendment)
5:02pm
of capital, increase loss of work time from key personnel, and negatively impact our key clinical trial vendors and supplier of our active pharmaceutical
POS AM
o3fzhnxg 8v30hnj5
6 Apr 21
Prospectus update (post-effective amendment)
12:00am
POS AM
ashskr3 wgqtrrgo
6 Apr 21
Prospectus update (post-effective amendment)
12:00am
8-K
EX-10.1
3bhv acdo
10 Dec 20
Entry into a Material Definitive Agreement
9:45am
POS AM
jzo6jzn
22 Apr 20
Prospectus update (post-effective amendment)
5:05pm
POS AM
s80jymby
22 Apr 20
Prospectus update (post-effective amendment)
5:04pm
- Prev
- 1
- Next